SYDNEY, AUSTRALIA: Wesfarmers Ltd has submitted a non-binding, indicative offer to acquire 100 percent of the shares outstanding in Australian Pharmaceutical Industries (API) for $1.38 per share by way of a scheme of arrangement, a news release said. The proposal price corresponds to a total equity value for Australian Pharmaceutical Industries (API) of approximately $687…
Tag: Australian Pharmaceutical Industries (API)
Australian Pharmaceutical Industries (API)
Australian Pharmaceutical Industries (API) is a health and beauty company in Australia that is involved in pharmaceutical distribution, retailing and manufacturing. API is Australia’s largest wholesale distributor of pharmaceutical and allied products. The company is involved in retailing through company-owned stores and franchise operations. API is listed on the Australian Securities Exchange and operates in…